166 related articles for article (PubMed ID: 6496881)
1. IgG subclass antibody response in grass pollen-allergic patients undergoing specific immunotherapy. Prognostic value of serum IgG subclass antibody levels early in immunotherapy.
Djurup R; Osterballe O
Allergy; 1984 Aug; 39(6):433-41. PubMed ID: 6496881
[TBL] [Abstract][Full Text] [Related]
2. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
Djurup R; Malling HJ; Søndergaard I; Weeke B
J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
[TBL] [Abstract][Full Text] [Related]
3. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.
van der Giessen M; Homan WL; van Kernbeek G; Aalberse RC; Dieges PH
Int Arch Allergy Appl Immunol; 1976; 50(5):625-40. PubMed ID: 773842
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
5. The subclass of IgG antibody in allergic disease: II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non-atopic individuals.
Kemeny DM; Urbanek R; Ewan P; McHugh S; Richards D; Patel S; Lessof MH
Clin Exp Allergy; 1989 Sep; 19(5):545-9. PubMed ID: 2790562
[TBL] [Abstract][Full Text] [Related]
6. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome.
Gehlhar K; Schlaak M; Becker W; Bufe A
Clin Exp Allergy; 1999 Apr; 29(4):497-506. PubMed ID: 10202364
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium.
Malling HJ; Djurup R
Allergy; 1988 Jan; 43(1):60-70. PubMed ID: 3344936
[TBL] [Abstract][Full Text] [Related]
8. IgG subclass antibody markers in grass pollen immunotherapy.
Moss RB
N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
[TBL] [Abstract][Full Text] [Related]
9. A three-layer immunoradiometric assay for determination of IgG subclass antibodies in human sera ("IgG subclass RAST"). Validation of the subclass specificity, and establishment of equipotency.
Djurup R; Søndergaard I; Magnusson CG; Weeke B
Allergy; 1984 Jan; 39(1):51-63. PubMed ID: 6607688
[TBL] [Abstract][Full Text] [Related]
10. Isotypic analysis of grass-pollen-specific immunoglobulins in human plasma. 2. Quantification of the IgE, IgM, IgA class and the IgG subclass antibodies.
Batard T; Basuyaux B; Laroze A; Lambin P; Brémard-Oury C; Aucouturier P; Hamilton RG; David B; Peltre G
Int Arch Allergy Immunol; 1993; 102(3):279-87. PubMed ID: 8219781
[TBL] [Abstract][Full Text] [Related]
11. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model.
Michils A; Vervier I; Choufani G; Gossart B; Duchateau J
Clin Exp Allergy; 1999 Jun; 29(6):832-9. PubMed ID: 10336601
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
13. Modifications in IgG subclasses in the course of immunotherapy with grass pollen.
García BE; Sanz ML; Diéguez I; de las Marinas MD; Oehling A
J Investig Allergol Clin Immunol; 1993; 3(1):19-25. PubMed ID: 8281327
[TBL] [Abstract][Full Text] [Related]
14. Evidence of a common regulation of IgE and IgG-subclass antibodies in humans during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1992 Oct; 47(5):467-70. PubMed ID: 1485649
[TBL] [Abstract][Full Text] [Related]
15. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy.
Djurup R
Allergy; 1985 Oct; 40(7):469-86. PubMed ID: 3907393
[TBL] [Abstract][Full Text] [Related]
16. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
18. A computational approach to the description of individual immune responses. IgE and IgG-subclass allergen-specific antibodies formed during immunotherapy.
Søndergaard I; Poulsen LK; Osterballe O; Weeke B
Allergy; 1991 Jan; 46(1):10-9. PubMed ID: 2018204
[TBL] [Abstract][Full Text] [Related]
19. The blocking activity of birch pollen-specific immunotherapy-induced IgG4 is not qualitatively superior to that of other IgG subclasses.
Ejrnaes AM; Bodtger U; Larsen JN; Svenson M
Mol Immunol; 2004 Jul; 41(5):471-8. PubMed ID: 15183926
[TBL] [Abstract][Full Text] [Related]
20. Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA).
Skov M; Pressler T; Jensen HE; Høiby N; Koch C
Thorax; 1999 Jan; 54(1):44-50. PubMed ID: 10343631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
